Tal Bliman Yael, Rafaeli Yehudai Tal, Shiber Yair, Mor Matan, Vaknin Zvi
Department of Obstetrics and Gynecology, The Yitzhak Shamir Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Zerifin.
Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Menopause. 2025 Jul 1. doi: 10.1097/GME.0000000000002600.
Pyometra is a rare but serious condition, particularly in postmenopausal women. While commonly linked to postpartum or post-surgical complications, spontaneous pyometra may also be associated with underlying gynecologic malignancies. We aim to examine the association between postmenopausal spontaneous pyometra (PMSP) and gynecologic cancers.
A retrospective review of consecutive women admitted with pyometra between 2007 and 2023, at a university-affiliated tertiary medical center. Demographic and clinical data were reviewed. Women with pyometra and gynecologic cancer were compared with those without.
Of 231 admissions for pyometra, 47 women with PMSP were identified. The cohort was divided into a benign group (n=35, 74.4%) and malignancy group (n=12, 25.6%). Endometrial carcinoma (n=8, 67%) was the predominant malignancy, followed by cervical cancer (n=4, 33%). Although age, age at menopause, and parity showed no significant statistical differences between the groups, a higher body mass index was significantly associated with endometrial malignancy (P = 0.014). Postmenopausal bleeding as an accompanying symptom to pyometra was also more common in the malignancy group (P=0.001). The prevalence of PMSP was 1.1% for endometrial cancer and 2.2% for cervical cancer.
PMSP is significantly associated with gynecologic malignancies, particularly endometrial and cervical cancers. Notably, women with endometrial malignancy had a higher BMI and were more likely to present with accompanying postmenopausal bleeding. These findings suggest that in postmenopausal women presenting with spontaneous pyometra, clinicians should maintain a high index of suspicion for malignancy. Early identification and appropriate management are crucial to improving patient outcomes.
子宫积脓是一种罕见但严重的病症,尤其在绝经后女性中。虽然通常与产后或术后并发症相关,但自发性子宫积脓也可能与潜在的妇科恶性肿瘤有关。我们旨在研究绝经后自发性子宫积脓(PMSP)与妇科癌症之间的关联。
对2007年至2023年期间在一所大学附属三级医疗中心因子宫积脓入院的连续女性患者进行回顾性研究。审查了人口统计学和临床数据。将患有子宫积脓和妇科癌症的女性与未患癌症的女性进行比较。
在231例子宫积脓入院患者中,确定了47例PMSP患者。该队列分为良性组(n = 35,74.4%)和恶性组(n = 12,25.6%)。子宫内膜癌(n = 8,67%)是主要的恶性肿瘤,其次是宫颈癌(n = 4,33%)。尽管两组之间的年龄、绝经年龄和产次无显著统计学差异,但较高的体重指数与子宫内膜恶性肿瘤显著相关(P = 0.014)。子宫积脓伴随的绝经后出血在恶性组中也更常见(P = 0.001)。子宫内膜癌患者中PMSP的患病率为1.1%,宫颈癌患者中为2.2%。
PMSP与妇科恶性肿瘤显著相关,尤其是子宫内膜癌和宫颈癌。值得注意的是,患有子宫内膜恶性肿瘤的女性体重指数较高,且更有可能出现伴随的绝经后出血。这些发现表明,在出现自发性子宫积脓的绝经后女性中,临床医生应高度怀疑恶性肿瘤。早期识别和适当管理对于改善患者预后至关重要。